Published in Biophys J on August 01, 1997
Barrel-stave model or toroidal model? A case study on melittin pores. Biophys J (2001) 3.80
Molecular dynamics simulation of melittin in a dimyristoylphosphatidylcholine bilayer membrane. Biophys J (1998) 2.16
Structure, location, and lipid perturbations of melittin at the membrane interface. Biophys J (2001) 1.96
Antimicrobial peptides: successes, challenges and unanswered questions. J Membr Biol (2011) 1.83
Mechanism and kinetics of pore formation in membranes by water-soluble amphipathic peptides. Proc Natl Acad Sci U S A (2008) 1.76
Mechanisms of antimicrobial, cytolytic, and cell-penetrating peptides: from kinetics to thermodynamics. Biochemistry (2009) 1.72
Two modes of exocytosis at hippocampal synapses revealed by rate of FM1-43 efflux from individual vesicles. J Cell Biol (2005) 1.72
Melittin-induced bilayer leakage depends on lipid material properties: evidence for toroidal pores. Biophys J (2004) 1.53
Membrane-active host defense peptides--challenges and perspectives for the development of novel anticancer drugs. Chem Phys Lipids (2011) 1.45
Selective membrane permeabilization by the rotavirus VP5* protein is abrogated by mutations in an internal hydrophobic domain. J Virol (2000) 1.40
Bilayer interactions of pHLIP, a peptide that can deliver drugs and target tumors. Biophys J (2008) 1.29
Structure of the alamethicin pore reconstructed by x-ray diffraction analysis. Biophys J (2008) 1.24
The nociceptive and anti-nociceptive effects of bee venom injection and therapy: a double-edged sword. Prog Neurobiol (2010) 1.23
Stability of a melittin pore in a lipid bilayer: a molecular dynamics study. Biophys J (2000) 1.21
Supramolecular structures of peptide assemblies in membranes by neutron off-plane scattering: method of analysis. Biophys J (1999) 1.17
Pores formed by Baxα5 relax to a smaller size and keep at equilibrium. Biophys J (2010) 1.16
On the mechanism of pore formation by melittin. J Biol Chem (2008) 1.13
Influence of lipid composition on membrane activity of antimicrobial phenylene ethynylene oligomers. J Phys Chem B (2008) 1.11
Membrane-induced folding of cecropin A. Biophys J (2000) 1.10
Peptide-lipid huge toroidal pore, a new antimicrobial mechanism mediated by a lactococcal bacteriocin, lacticin Q. Antimicrob Agents Chemother (2009) 1.10
Free energies of molecular bound states in lipid bilayers: lethal concentrations of antimicrobial peptides. Biophys J (2009) 1.09
Process of inducing pores in membranes by melittin. Proc Natl Acad Sci U S A (2013) 1.09
Non-metabolic membrane tubulation and permeability induced by bioactive peptides. PLoS One (2007) 1.07
Controlled alteration of the shape and conformational stability of alpha-helical cell-lytic peptides: effect on mode of action and cell specificity. Biochem J (2005) 1.05
Mechanisms of alpha-defensin bactericidal action: comparative membrane disruption by Cryptdin-4 and its disulfide-null analogue. Biochemistry (2008) 1.04
Structure of (KIAGKIA)3 aggregates in phospholipid bilayers by solid-state NMR. Biophys J (2004) 1.03
Proapoptotic Bax and Bak proteins form stable protein-permeable pores of tunable size. J Biol Chem (2013) 1.01
Antimicrobial peptides bind more strongly to membrane pores. Biochim Biophys Acta (2010) 0.99
A lipocentric view of peptide-induced pores. Eur Biophys J (2011) 0.98
A "release" protocol for isothermal titration calorimetry. Biophys J (1999) 0.98
Antimicrobial peptides temporins B and L induce formation of tubular lipid protrusions from supported phospholipid bilayers. Biophys J (2006) 0.97
Antimicrobial properties and membrane-active mechanism of a potential α-helical antimicrobial derived from cathelicidin PMAP-36. PLoS One (2014) 0.97
Energetics and self-assembly of amphipathic peptide pores in lipid membranes. Biophys J (2003) 0.96
A critical reassessment of penetratin translocation across lipid membranes. Biophys J (2005) 0.96
Antimicrobial peptides in toroidal and cylindrical pores. Biochim Biophys Acta (2010) 0.95
The lipid dependence of melittin action investigated by dual-color fluorescence burst analysis. Biophys J (2007) 0.95
Polar angle as a determinant of amphipathic alpha-helix-lipid interactions: a model peptide study. Biophys J (2000) 0.95
Nanoscale imaging reveals laterally expanding antimicrobial pores in lipid bilayers. Proc Natl Acad Sci U S A (2013) 0.94
Charge distribution and imperfect amphipathicity affect pore formation by antimicrobial peptides. Biochim Biophys Acta (2012) 0.93
Thermally induced proliferation of pores in a model fluid membrane. Biophys J (1998) 0.92
Interaction of the gelsolin-derived antibacterial PBP 10 peptide with lipid bilayers and cell membranes. Antimicrob Agents Chemother (2006) 0.90
Orientation of the pore-forming peptide GALA in POPC vesicles determined by a BODIPY-avidin/biotin binding assay. Biophys J (1999) 0.87
Effect of phospholipid composition on an amphipathic peptide-mediated pore formation in bilayer vesicles. Biophys J (2000) 0.85
An antimicrobial peptide that targets DNA repair intermediates in vitro inhibits Salmonella growth within murine macrophages. Antimicrob Agents Chemother (2010) 0.84
Kinetic models for peptide-induced leakage from vesicles and cells. Eur Biophys J (2007) 0.83
The dynamics of melittin-induced membrane permeability. Eur Biophys J (2012) 0.82
Permeation of styryl dyes through nanometer-scale pores in membranes. Biochemistry (2011) 0.82
The structure of a melittin-stabilized pore. Biophys J (2015) 0.81
Role of nanoparticle surface functionality in the disruption of model cell membranes. Langmuir (2012) 0.81
Phospholipid flip-flop modulated by transmembrane peptides WALP and melittin. J Struct Biol (2009) 0.81
Membrane surface-associated helices promote lipid interactions and cellular uptake of human calcitonin-derived cell penetrating peptides. Biophys J (2005) 0.80
A synthetic S6 segment derived from KvAP channel self-assembles, permeabilizes lipid vesicles, and exhibits ion channel activity in bilayer lipid membrane. J Biol Chem (2011) 0.80
Multiple membrane interactions and versatile vesicle deformations elicited by melittin. Toxins (Basel) (2013) 0.80
A Peptidomimetic Antibiotic Targets Outer Membrane Proteins and Disrupts Selectively the Outer Membrane in Escherichia coli. J Biol Chem (2015) 0.80
NMR structure of a viral peptide inserted in artificial membranes: a view on the early steps of the birnavirus entry process. J Biol Chem (2010) 0.79
N-terminal proline-rich domain is required for scrambling activity of human phospholipid scramblases. J Biol Chem (2014) 0.78
Combined systems approaches reveal a multistage mode of action of a marine antimicrobial peptide against pathogenic Escherichia coli and its protective effect against bacterial peritonitis and endotoxemia. Antimicrob Agents Chemother (2016) 0.77
Triatoma virus recombinant VP4 protein induces membrane permeability through dynamic pores. J Virol (2015) 0.76
Kinetic Defects Induced by Melittin in Model Lipid Membranes: A Solution Atomic Force Microscopy Study. J Phys Chem B (2016) 0.76
Mode of Action of Antimicrobial Peptides on E. coli Spheroplasts. Biophys J (2016) 0.76
Antifungal Activity of a Synthetic Cationic Peptide against the Plant Pathogens Colletotrichum graminicola and Three Fusarium Species. Plant Pathol J (2015) 0.75
Preparation and Characterization of Gelonin-Melittin Fusion Biotoxin for Synergistically Enhanced Anti-Tumor Activity. Pharm Res (2016) 0.75
Membrane Active Antimicrobial Peptides: Translating Mechanistic Insights to Design. Front Neurosci (2017) 0.75
Engineering monolayer poration for rapid exfoliation of microbial membranes. Chem Sci (2016) 0.75
Measuring melittin uptake into hydrogel nanoparticles with near-infrared single nanoparticle surface plasmon resonance microscopy. Anal Chem (2015) 0.75
Lipid topology and electrostatic interactions underpin lytic activity of linear cationic antimicrobial peptides in membranes. Proc Natl Acad Sci U S A (2017) 0.75
Phosphorus assay in column chromatography. J Biol Chem (1959) 60.56
Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature (1981) 5.66
A voltage-gated ion channel model inferred from the crystal structure of alamethicin at 1.5-A resolution. Nature (1982) 4.92
The actions of melittin on membranes. Biochim Biophys Acta (1990) 4.04
Membrane pores induced by magainin. Biochemistry (1996) 3.97
An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry (1996) 3.16
Neutron scattering in the plane of membranes: structure of alamethicin pores. Biophys J (1996) 2.63
The biophysics of peptide models of ion channels. Prog Biophys Mol Biol (1991) 2.59
The structure of melittin in the form I crystals and its implication for melittin's lytic and surface activities. Biophys J (1982) 2.50
G protein activation: a receptor-independent mode of action for cationic amphiphilic neuropeptides and venom peptides. Trends Pharmacol Sci (1990) 2.32
Orientation of melittin in phospholipid bilayers. A polarized attenuated total reflection infrared study. Biophys J (1991) 2.27
Comparison of the conformation and orientation of alamethicin and melittin in lipid membranes. Biochemistry (1987) 2.15
Kinetics and mechanism of hemolysis induced by melittin and by a synthetic melittin analogue. Biophys J (1982) 2.03
Orientational and aggregational states of magainin 2 in phospholipid bilayers. Biochemistry (1994) 1.94
Translocation of a channel-forming antimicrobial peptide, magainin 2, across lipid bilayers by forming a pore. Biochemistry (1995) 1.93
Mechanism of alamethicin insertion into lipid bilayers. Biophys J (1996) 1.92
Mechanism of leakage of phospholipid vesicle contents induced by the peptide GALA. Biochemistry (1990) 1.86
Voltage-dependent trans-bilayer orientation of melittin. J Biol Chem (1982) 1.86
Thermodynamic and kinetic studies on the association of melittin with a phospholipid bilayer. Biochim Biophys Acta (1989) 1.50
Dynamics and aggregation of the peptide ion channel alamethicin. Measurements using spin-labeled peptides. Biophys J (1991) 1.45
Pore-forming peptides induce rapid phospholipid flip-flop in membranes. Biochemistry (1994) 1.43
Study of vesicle leakage induced by melittin. Biochim Biophys Acta (1995) 1.40
The aggregation state of spin-labeled melittin in solution and bound to phospholipid membranes: evidence that membrane-bound melittin is monomeric. Proteins (1988) 1.38
Morphological changes of phosphatidylcholine bilayers induced by melittin: vesicularization, fusion, discoidal particles. Biochim Biophys Acta (1986) 1.35
Cell-lytic and antibacterial peptides that act by perturbing the barrier function of membranes: facets of their conformational features, structure-function correlations and membrane-perturbing abilities. Biochim Biophys Acta (1994) 1.29
Modulation of magainin 2-lipid bilayer interactions by peptide charge. Biochemistry (1997) 1.24
Kinetics of melittin induced pore formation in the membrane of lipid vesicles. Biochim Biophys Acta (1992) 1.24
Pore kinetics reflected in the dequenching of a lipid vesicle entrapped fluorescent dye. Biochim Biophys Acta (1995) 1.23
Kinetics of pore formation by an antimicrobial peptide, magainin 2, in phospholipid bilayers. Biochemistry (1995) 1.20
Transbilayer transport of ions and lipids coupled with mastoparan X translocation. Biochemistry (1996) 1.17
Action mechanism of amphipathic peptides gramicidin S and melittin on erythrocyte membrane. Biochim Biophys Acta (1988) 1.15
Vesicle-bound conformation of melittin: transferred nuclear Overhauser enhancement analysis in the presence of perdeuterated phosphatidylcholine vesicles. Biochemistry (1994) 1.14
Aggregation state of melittin in lipid vesicle membranes. Biophys J (1991) 1.14
The aggregation state of mellitin in lipid bilayers. An energy transfer study. J Biol Chem (1986) 1.11
Leakage of internal markers from erythrocytes and lipid vesicles induced by melittin, gramicidin S and alamethicin: a comparative study. Biochim Biophys Acta (1990) 1.10
Kinetics of pore-mediated release of marker molecules from liposomes or cells. Biophys Chem (1992) 1.02
Primary structure of peptides and ion channels. Role of amino acid side chains in voltage gating of melittin channels. Biophys J (1990) 0.99
Osmotic and pH transmembrane gradients control the lytic power of melittin. Biophys J (1996) 0.99
A comparative study of band 3 aggregation in erythrocyte membranes by melittin and other cationic agents. Biochim Biophys Acta (1989) 0.92
Melittin induced voltage-dependent conductance in DOPC lipid bilayers. Biochim Biophys Acta (1991) 0.89
A combined study of aggregation, membrane affinity and pore activity of natural and modified melittin. Biochim Biophys Acta (1991) 0.89
The influence of melittin on the rotation of band 3 protein in the human erythrocyte membrane. Eur Biophys J (1984) 0.87
Magainin-2 releases histamine from rat mast cells. Proc Soc Exp Biol Med (1990) 0.86
An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry (1996) 3.16
Relationship of membrane curvature to the formation of pores by magainin 2. Biochemistry (1998) 2.18
Molecular basis for membrane selectivity of an antimicrobial peptide, magainin 2. Biochemistry (1995) 2.18
Orientational and aggregational states of magainin 2 in phospholipid bilayers. Biochemistry (1994) 1.94
Translocation of a channel-forming antimicrobial peptide, magainin 2, across lipid bilayers by forming a pore. Biochemistry (1995) 1.93
Physicochemical determinants for the interactions of magainins 1 and 2 with acidic lipid bilayers. Biochim Biophys Acta (1991) 1.65
Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. Biochim Biophys Acta (1997) 1.59
DNA methylation profiles of lung tumors. Mol Cancer Ther (2001) 1.53
Pleomorphic leiomyosarcoma: clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma. Am J Surg Pathol (2001) 1.48
Magainin 1-induced leakage of entrapped calcein out of negatively-charged lipid vesicles. Biochim Biophys Acta (1989) 1.46
Mechanism of synergism between antimicrobial peptides magainin 2 and PGLa. Biochemistry (1998) 1.45
Modulation of magainin 2-lipid bilayer interactions by peptide charge. Biochemistry (1997) 1.24
Kinetics of pore formation by an antimicrobial peptide, magainin 2, in phospholipid bilayers. Biochemistry (1995) 1.20
Membrane permeabilization mechanisms of a cyclic antimicrobial peptide, tachyplesin I, and its linear analog. Biochemistry (1997) 1.18
Transbilayer transport of ions and lipids coupled with mastoparan X translocation. Biochemistry (1996) 1.17
The protective effects of prostaglandin E1 in an experimental massive hepatic cell necrosis model. Hepatology (1988) 1.13
p53 Mutation and MDM2 amplification in inflammatory myofibroblastic tumours. Histopathology (2003) 1.11
Interactions of an antimicrobial peptide, magainin 2, with lipopolysaccharide-containing liposomes as a model for outer membranes of gram-negative bacteria. FEBS Lett (1999) 1.10
Optical characterization of liposomes by right angle light scattering and turbidity measurement. Biochim Biophys Acta (2000) 1.06
Correction of single-tooth crossbite. J Clin Orthod (1995) 0.99
[Effects of the Chinese prescription "inchinko-to" on intrahepatic cholestasis induced by the cholestatic factor]. Nihon Shokakibyo Gakkai Zasshi (1985) 0.97
Interactions of an antimicrobial peptide, tachyplesin I, with lipid membranes. Biochim Biophys Acta (1991) 0.92
Vaccines targeting tumour angiogenesis--a novel strategy for cancer immunotherapy. Eur J Surg Oncol (2006) 0.91
Preventive effects of glycaemic control on ocular complications of Spontaneously Diabetic Torii rat. Diabetes Obes Metab (2006) 0.91
Correlation between lead in plasma and other indicators of lead exposure among lead-exposed workers. Int Arch Occup Environ Health (1995) 0.89
Effects of sphingomyelin and cholesterol on lipoprotein lipase-mediated lipolysis in lipid emulsions. J Lipid Res (1998) 0.88
Effects of glucose and its oligomers on the stability of freeze-dried liposomes. Biochim Biophys Acta (1996) 0.88
Role of disulfide linkages in tachyplesin-lipid interactions. Biochemistry (1993) 0.88
Phospholipid monolayers at the triolein-saline interface: production of microemulsion particles and conversion of monolayers to bilayers. Biochemistry (1990) 0.87
Calcified pseudoaneurysm of the left ventricle. Can J Cardiol (1998) 0.86
Protein kinase C beta inhibitor prevents diabetic peripheral neuropathy, but not histopathological abnormalities of retina in Spontaneously Diabetic Torii rat. Diabetes Obes Metab (2009) 0.86
Regulation of phospholipase D activity by neutral lipids in egg-yolk phosphatidylcholine small unilamellar vesicles and by calcium ion in aqueous medium. Biochim Biophys Acta (1995) 0.85
Effect of cholesterol on apolipoprotein A-I binding to lipid bilayers and emulsions. J Lipid Res (1997) 0.85
Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients. Intern Med (1999) 0.85
MRI of anterior spinal artery syndrome. J Neurol Neurosurg Psychiatry (1992) 0.85
Physical-chemistry characteristics and biodistribution of poly(ethylene glycol)-coated liposomes using poly(oxyethylene) cholesteryl ether. Chem Pharm Bull (Tokyo) (1995) 0.84
A comparative study on interactions of alpha-aminoisobutyric acid containing antibiotic peptides, trichopolyn I and hypelcin A with phosphatidylcholine bilayers. Biochim Biophys Acta (1991) 0.83
Effectiveness of an antiplatelet agent for coronary artery ectasia associated with silent myocardial ischemia. Jpn Heart J (2001) 0.82
Cholesterol derivative of poly(ethylene glycol) inhibits clathrin-independent, but not clathrin-dependent endocytosis. Biochim Biophys Acta (1997) 0.81
Hypelcin A, an alpha-aminoisobutyric acid containing antibiotic peptide, induced permeability change of phosphatidylcholine bilayers. Biochemistry (1989) 0.81
A new HPLC fluorimetric method to monitor urinary delta-aminolevulinic acid (ALA-U) levels in workers exposed to lead. Int Arch Occup Environ Health (1989) 0.81
[Identification of urinary metabolites in a patient of acute poisoning by p-chloroaniline]. Sangyo Igaku (1991) 0.81
Poly(ethylene glycol) derivative of cholesterol reduces binding step of liposome uptake by murine macrophage-like cell line J774 and human hepatoma cell line HepG2. Chem Pharm Bull (Tokyo) (1998) 0.81
Binding and uptake of liposomes containing a poly(ethylene glycol) derivative of cholesterol (stealth liposomes) by the macrophage cell line J774: influence of PEG content and its molecular weight. Biochim Biophys Acta (1996) 0.81
Effects of antibacterial agents, levofloxacin and clarithromycin, on aquatic organisms. Water Sci Technol (2006) 0.81
Calponin and h-caldesmon expression in atypical fibroxanthoma and superficial leiomyosarcoma. Virchows Arch (2001) 0.80
Physical states of surface and core lipids in lipid emulsions and apolipoprotein binding to the emulsion surface. J Biol Chem (1996) 0.80
Acute basophilic leukaemia in a calf. Vet Rec (2006) 0.80
t(7;11) and trilineage myelodysplasia in acute myelomonocytic leukemia. Cancer Genet Cytogenet (1996) 0.80
Genetic Diversity of Xanthomonas oryzae pv. oryzae Strains from Sri Lanka. Phytopathology (2000) 0.79
Fourteen-day oral combination dose toxicity study of CGS 16949 A (aromatase inhibitor) with 5-fluorouracil or tamoxifen in rats. J Toxicol Sci (1997) 0.78
Cardioprotective effect of TY-12533, a novel Na(+)/H(+) exchange inhibitor, on ischemia/reperfusion injury. Eur J Pharmacol (2000) 0.78
Differential expression of wheat genes during cold acclimation. Tsitol Genet (2007) 0.78
Incidence of cleft lip and palate in beagles. Plast Reconstr Surg (1994) 0.78
A dynamic change by 123I-15-(p-iodophenyl)-3-R,S-methyl pentadecanoic acid myocardial single photon emission computed tomography in a 55-year-old woman. Jpn Circ J (1999) 0.78
[Two cases of microvascular vasospastic angina usefulness of 99mTc-tetrofosmin myocardial SPECT in clinical diagnosis]. Kaku Igaku (2000) 0.78
[A chromosome analysis in a patient with chronic myelogenous leukemia and gastric cancer (author's transl)]. Nihon Ketsueki Gakkai Zasshi (1981) 0.78
Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain. Neurosci Lett (1996) 0.78
Gene expression and genetic mapping analyses of a perennial ryegrass glycine-rich RNA-binding protein gene suggest a role in cold adaptation. Mol Genet Genomics (2006) 0.78
Significance of subclinical entrapment of nerves in lead neuropathy. Environ Res (1993) 0.77
Effect of the interaction of drug-beta-cyclodextrin complex with bile salts on the drug absorption from rat small intestinal lumen. Chem Pharm Bull (Tokyo) (1989) 0.77
Gastric ulcer healing and basic fibroblast growth factor: effects of lansoprazole and famotidine. J Clin Gastroenterol (1995) 0.77
Rapid and high yield induction of endometrial adenocarcinomas in CD-1 mice by a single intrauterine administration of N-ethyl-N-nitrosourea combined with chronic 17 beta-estradiol treatment. Cancer Lett (1996) 0.77
Effect of cyclodextrins on biological membrane. II. Mechanism of enhancement on the intestinal absorption of non-absorbable drug by cyclodextrins. Chem Pharm Bull (Tokyo) (1992) 0.77
Can serum carnitine levels distinguish hypertrophic cardiomyopathy from hypertensive hearts? Hypertension (2000) 0.77
Retroperitoneal bronchogenic cyst: a rare case showing the characteristic imaging feature of milk of calcium. Abdom Imaging (2003) 0.77
PF1092A, B and C, new nonsteroidal progesterone receptor ligands produced by Penicillium oblatum. II. Physico-chemical properties and structure elucidation. J Antibiot (Tokyo) (1997) 0.77
Effects of 1,2-diacylglycerol and cholesterol on the hydrolysis activity of phospholipase D in egg-yolk phosphatidylcholine bilayers. Biochim Biophys Acta (1993) 0.77
Detection of the cholestatic factor in the liver tissue of patients with acute intrahepatic cholestasis. Ann Allergy (1986) 0.77
Beneficial effect of nipradilol (K-351) on acute myocardial ischemia. Study of the relationship between regional myocardial blood flow and energy metabolism. Jpn J Pharmacol (1990) 0.77
Elevated serum levels of manganese superoxide dismutase in polymyositis and dermatomyositis. Neurology (1996) 0.77
[The usefulness of 123I-BMIPP myocardial SPECT in diagnosis for silent myocardial ischemia induced by vasospasm]. Kaku Igaku (1999) 0.76
Lateral interactions of pig apolipoprotein A-1 with egg yolk phosphatidylcholine and with cholesterol in mixed monolayers at the triolein-saline interface. Biochemistry (1992) 0.76
Initiating and promoting effects of concurrent oral administration of ethylenethiourea and sodium nitrite on uterine endometrial adenocarcinoma development in Donryu rats. In Vivo (1998) 0.76
High-efficiency entrapment of superoxide dismutase into cationic liposomes containing synthetic aminoglycolipid. Chem Pharm Bull (Tokyo) (1997) 0.76
Effects of cholesterol and cholesteryl oleate on lipolysis and liver uptake of triglyceride/phosphatidylcholine emulsions in rats. Pharm Res (1994) 0.75
The effect of shift work on cellular immune function. J Hum Ergol (Tokyo) (1982) 0.75
Eutectic mixed monolayers in equilibrium with phospholipid-bilayers and triolein-liquid phase. Biophys J (1993) 0.75
Root resorption. J Am Dent Assoc (1989) 0.75
[Antitumor activity of shi-quan-da-bu-tang and its effects on interferon-gamma and interleukin 2 production]. Arerugi (1988) 0.75
[Findings on trichomonas vaginitis--from the view of uterine cancer examination]. Saishin Igaku (1966) 0.75
[The protective effect of gomisin A on experimentally induced acute hepatic injury]. Nihon Shokakibyo Gakkai Zasshi (1987) 0.75
Effect of saccharides on the freezing and thawing of liposome dispersion. Chem Pharm Bull (Tokyo) (1986) 0.75
[Studies on an experimentally-induced acute hepatic failure in mice: low productivity of interleukin 1 and 2]. Nihon Shokakibyo Gakkai Zasshi (1987) 0.75
[A severe case of drug-induced allergic hepatitis in herbal medicine]. Nihon Naika Gakkai Zasshi (1986) 0.75
[Studies on an experimentally induced acute hepatic failure in mice: difference between the hepatotoxic factor and tumor necrosis factor]. Nihon Shokakibyo Gakkai Zasshi (1986) 0.75
[The effects of xiao-chai-hu-tang (syosaiko-to) on lymphokine-activated killer (LAK) cell activity]. Arerugi (1986) 0.75
[Intrahepatic cholestasis induced by heat-killed Propionibacterium acnes in the tuberculin-sensitized guinea pig]. Nihon Shokakibyo Gakkai Zasshi (1986) 0.75
[Studies on experimentally induced acute hepatic failure in mice. Characteristics of the hepatocytotoxic factors released from the activated liver adherent cells]. Nihon Shokakibyo Gakkai Zasshi (1986) 0.75
Experimental immunological intrahepatic cholestasis model. Gastroenterol Jpn (1988) 0.75
Quantitative analysis of hemolytic action of lysophosphatidylcholines in vitro: effect of acyl chain structure. Chem Pharm Bull (Tokyo) (1988) 0.75
[Estradiol binding capacity of peripheral blood mononuclear cells from asymptomatic HBV carriers]. Nihon Shokakibyo Gakkai Zasshi (1987) 0.75
[Tricuspid regurgitation evaluated by intraoperative epicardial pulsed Doppler echocardiography: investigation of patients with combined valvular diseases]. J Cardiol (1987) 0.75
Detection of the cholestatic factor in the liver tissue of patients with acute intrahepatic cholestasis. Gastroenterol Jpn (1987) 0.75
[Augmentation of drug-induced lymphocyte transformation by indomethacin in patients with drug-induced allergic hepatitis]. Nihon Shokakibyo Gakkai Zasshi (1987) 0.75
[Mitral stenosis of the postoperative state evaluated by echocardiography]. J Cardiogr (1986) 0.75
[Mechanism of intrahepatic cholestasis induced by heat-killed propionibacterium acnes in the tuberculin-sensitized guinea pig]. Nihon Shokakibyo Gakkai Zasshi (1987) 0.75